US Archives - Page 77 of 165 - European Medical Journal

RSV Poses Greater Heart Risk Than COVID or Flu

Adults hospitalized with respiratory syncytial virus (RSV) face a significantly greater risk of acute cardiovascular events compared to those admitted for COVID-19 or influenza, according to new findings from a population-based study.

Rising Threat: Candida Eye Infections Demand Urgent Action

Candida endophthalmitis and chorioretinitis, sight-threatening complications of candidemia, are on the rise and require faster, more coordinated care, according to a recent review.

Rheumatoid Arthritis Raises Tuberculosis Risk Despite Screening

In a major new study of over 350,000 individuals, researchers have uncovered compelling evidence that patients with rheumatoid arthritis face a significantly higher risk of developing active pulmonary tuberculosis, even in modern healthcare settings where tuberculosis screening precedes biologic treatment.

Laser Dermatology in the US: Are Patients Sacrificing Safety for Speed?

A new study reveals major differences in cosmetic laser practices across US dermatologists, plastic surgeons, and medical spas. Key findings raise patient safety concerns and emphasize the importance of specialized training.

City Living Raises Asthma Risk Across the Lifespan

Long-term exposure to urban environmental factors, particularly air pollution, lack of green space, and dense built environments, significantly increases the risk of developing asthma across the life course, according to a large-scale analysis involving 14 European cohorts and more than 340,000 participants.

Women’s Body Image After Mastectomy Reveal Deep Psychosocial Impact

A new study exploring women’s body image after mastectomy sheds light on the complex emotional and psychosocial challenges these patients face during and after breast cancer treatment.

Why Delirium Prediction Models Often Fail Doctors

Delirium remains a critical yet often underrecognized condition in acute care settings with direct links to increased mortality and extended hospital stays.

Immunotherapy After Surgery May Reduce HNSCC Recurrence: ASCO 2025

Adding nivolumab to postoperative chemoradiotherapy may reduce the likelihood of recurrence in patients with resected, high-risk head and neck squamous cell carcinoma (HNSCC), according to results from the Phase III NIVOPOSTOP trial presented at the 2025 ASCO Annual Meeting.

PD-L1-Positive TNBC Sees Slower Disease Growth: ASCO 2025

Patients with unresectable, locally advanced or metastatic PD-L1-positive triple-negative breast cancer (TNBC) experienced longer progression-free survival when treated with sacituzumab govitecan and pembrolizumab, compared to the current standard of chemotherapy plus pembrolizumab, according to new findings presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

β-Lactams Outperform Vancomycin in MSSA Treatment

IN a new meta-analysis, β-lactam antibiotics demonstrated significantly faster clinical response times than vancomycin in patients with methicillin-sensitive Staphylococcus aureus (MSSA) bloodstream infections, suggesting a potential shift in first-line treatment choices.